These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16401944)

  • 1. Management of antitubercular drugs-induced hepatotoxicity and therapy reintroduction strategy in a TB clinic of Nepal.
    Shakya R; Rao BS; Shrestha B
    Kathmandu Univ Med J (KUMJ); 2005; 3(1):45-9. PubMed ID: 16401944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of anti-tuberculosis drug-induced hepatotoxicity.
    Tahaoğlu K; Ataç G; Sevim T; Tärün T; Yazicioğlu O; Horzum G; Gemci I; Ongel A; Kapakli N; Aksoy E
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):65-9. PubMed ID: 11263519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: A cohort study.
    Wondwossen Abera ; Waqtola Cheneke ; Gemeda Abebe
    Int J Mycobacteriol; 2016 Mar; 5(1):14-20. PubMed ID: 26927985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regarding "Management of antitubercular drug-induced hepatotoxicity and therapy reintroduction strategy in a TB clinic of Nepal".
    Anupa KC; Bista D
    Kathmandu Univ Med J (KUMJ); 2005; 3(3):310. PubMed ID: 18661667
    [No Abstract]   [Full Text] [Related]  

  • 5. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
    Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of hepatotoxicity due to antitubercular medicines and assessment of risk factors.
    Shakya R; Rao BS; Shrestha B
    Ann Pharmacother; 2004 Jun; 38(6):1074-9. PubMed ID: 15122004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring and management of antituberculosis drug induced hepatotoxicity.
    Agal S; Baijal R; Pramanik S; Patel N; Gupte P; Kamani P; Amarapurkar D
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1745-52. PubMed ID: 16246196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing Hepatotoxicity Caused by Anti-tuberculosis Drugs: A Comparative Study of Approaches.
    Abbaspour F; Hasannezhad M; Khalili H; SeyedAlinaghi S; Jafari S
    Arch Iran Med; 2024 Mar; 27(3):122-126. PubMed ID: 38685836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus.
    Ungo JR; Jones D; Ashkin D; Hollender ES; Bernstein D; Albanese AP; Pitchenik AE
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1871-6. PubMed ID: 9620920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity.
    Singla R; Sharma SK; Mohan A; Makharia G; Sreenivas V; Jha B; Kumar S; Sarda P; Singh S
    Indian J Med Res; 2010 Jul; 132():81-6. PubMed ID: 20693595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antituberculosis drugs and hepatotoxicity among hospitalized patients in Jos, Nigeria.
    Isa SE; Ebonyi AO; Shehu NY; Idoko P; Anejo-Okopi JA; Simji G; Odesanya RU; Abah IO; Jimoh HO
    Int J Mycobacteriol; 2016 Mar; 5(1):21-6. PubMed ID: 26927986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation.
    Ichai P; Saliba F; Antoun F; Azoulay D; Sebagh M; Antonini TM; Escaut L; Delvart V; Castaing D; Samuel D
    Liver Transpl; 2010 Oct; 16(10):1136-46. PubMed ID: 20879012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis.
    Park WB; Kim W; Lee KL; Yim JJ; Kim M; Jung YJ; Kim NJ; Kim DH; Kim YJ; Yoon JH; Oh MD; Lee HS
    J Infect; 2010 Oct; 61(4):323-9. PubMed ID: 20670648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk assessment of hepatotoxicity among tuberculosis and human immunodeficiency virus/AIDS-coinfected patients under tuberculosis treatment.
    Ngouleun W; Biapa Nya PC; Pieme AC; Telefo PB
    Int J Mycobacteriol; 2016 Dec; 5(4):482-488. PubMed ID: 27931691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight loss during tuberculosis treatment is an important risk factor for drug-induced hepatotoxicity.
    Warmelink I; ten Hacken NH; van der Werf TS; van Altena R
    Br J Nutr; 2011 Feb; 105(3):400-8. PubMed ID: 20875187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the physicians' approach to the diagnosis and treatment of patients with antituberculosis drug-induced hepatotoxicity.
    Thongraung W; Sittidach M; Khwansuwan P; Sariyasuntorn K; Wongsampan S
    J Eval Clin Pract; 2012 Dec; 18(6):1119-25. PubMed ID: 21696520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of reintroducing anti-tuberculosis drugs following cutaneous adverse drug reactions.
    Lehloenya RJ; Todd G; Badri M; Dheda K
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1649-57. PubMed ID: 22118173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury.
    Devarbhavi H; Singh R; Patil M; Sheth K; Adarsh CK; Balaraju G
    J Gastroenterol Hepatol; 2013 Jan; 28(1):161-7. PubMed ID: 23020522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.